STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN
Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex form...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex forming agent, have been encountered. It was unexpectedly found that these difficulties can be overcome by adjusting the pH of the solution with an aci d to over and above 8,2, preferably to 9,0, but not higher than 10. |
---|